article thumbnail

Leading retail pharmacies in pharma

Pharmaceutical Technology

Increasing diagnosis of chronic diseases is expected to lead to fast growth in retail pharmacies. The rising incidence of long-standing diseases such as hypertension, diabetes, cardiovascular diseases, and cancer requires prolonged medication and, thus, drives the growth and need for retail pharmacies in the market. Speciality care.

Retail 59
article thumbnail

A Powerful Point-of-Sale Partnership that Delivers on the Promise of Affordable Insulin

PM360

In March of this year the three largest insulin manufacturers announced a dramatic reduction in the price of many commonly prescribed insulins and a monthly out-of-pocket (OOP) cap of $35 that went into effect in May. retail pharmacies to access a 30-day supply of Lantus for only $35. References: 1.

Retail 52
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Leading pharmaceutical wholesalers

Pharmaceutical Technology

Pharmaceutical wholesalers act as intermediaries between pharmaceutical manufacturers and retailers and facilitate the delivery of the right medicines in a timely, efficient, and secure manner. Wholesale distributors are responsible for guaranteeing product quality and preventing the influx of counterfeited drugs. GDP and GMP advisory.

Leads 52
article thumbnail

Revolutionizing MedTech: Dive Into Medical Sales Strategies With Paul Hoffschmidt

Evolve Your Success

Picture a tool that does more than just scratch the surface; we’re talking about a deep dive into healthcare practitioner’s activities, from the operating room to prescription trends. Over the past decade, he has been a regular angel investor and company builder, typically focusing on data-driven topics.

article thumbnail

US legislative update: takeaways for European pharma

European Pharmaceutical Review

In the current US Congressional session, Congress has focused heavily on legislation directed at reducing prescription drug prices. The new law will also require drug manufacturers to pay rebates to Medicare if they increase drug prices faster than consumer inflation. 5) monitoring access to biosimilars.

article thumbnail

4 Ways to Meet the Needs of an Increasing Health-conscious Audience

PM360

Consider the SmartLabel Digital Transparency Initiative, which was created by the Grocery Manufacturers Association and the Food Industry Association under the manufacturing companies’ and retailers’ parity-based entity called the Trading Partner Alliance in 2016. Understand the Changing Retail Strategy Landscape.

Retail 97
article thumbnail

Walmart offers $3.1bn to settle opioid epidemic lawsuits

pharmaphorum

Walmart has become the latest big pharmacy chain in the US to put forward a settlement to resolve claims it contributed to the national opioid crisis by failing to regulate prescriptions at its outlets. The retail giant has confirmed it has offered $3.1 billion for Teva Pharmaceutical , $2.4 billion for AbbVie, $1.7